Status:
COMPLETED
Intravitreal Bevacizumab for Neovascular Glaucoma
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Neovascular
Glaucoma
Eligibility:
All Genders
10-80 years
Phase:
NA
Brief Summary
Several studies have confirmed high levels of vascular endothelial growth factor (VEGF) in eyes with neovascular glaucoma (NVG). The role of VEGF inhibitors in regression of other neovascular disorder...
Eligibility Criteria
Inclusion
- Clinical diagnosis of NVG
- Vision less than 20/200
- age 10-80 years
Exclusion
- Uncontrolled Blood Pressure
- History of thromboembolism
- Congestive Heart Failure
- Renal Failure
- Pregnancy or Lactation
- Active ocular or periocular infection
- No light perception
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00384631
Start Date
April 1 2006
End Date
March 1 2007
Last Update
February 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Labbafinejad Medical Center
Tehran, Tehran Province, Iran, 16666